![Christopher Loose](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Loose
Keine laufenden Positionen mehr
Profil
Christopher R.
Loose was the founder of Semprus BioSciences Corp., founded in 2007, serving as Chief Technology Officer from 2007 to 2012.
Dr. Loose was the founder of Frequency Therapeutics, Inc., founded in 2014, serving as Chief Scientific Officer in 2023.
Loose is also the founder of Progentos Therapeutics, Inc...
Dr. Loose is Executive Director at the Center For Integration of Medicine & Innovative Technology.
Loose is Executive Director at Yale School of Medicine since 2014.
Loose was Principal at Merck Research Laboratories Massachusetts LLC from 2002 to 2003.
Loose was Chief Scientific Officer at Korro Bio, Inc. Dr. Loose earned a doctorate from Massachusetts Institute of Technology in 2007.
Loose earned an undergraduate degree from Princeton University in 2002.
Aktive Positionen von Christopher Loose
| Unternehmen | Position | Beginn |
|---|---|---|
Yale School of Medicine
 Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Direktor/Vorstandsmitglied | 01.06.2014 |
Center For Integration of Medicine & Innovative Technology | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Christopher Loose
| Unternehmen | Position | Ende |
|---|---|---|
| KORRO BIO, INC. | Vorstandsvorsitzender | 07.03.2023 |
Semprus BioSciences Corp.
 Semprus BioSciences Corp. Pharmaceuticals: GenericHealth Technology Develops medical devices for anti-microbial coating to reduce bloodstream infections | Gründer | 01.06.2012 |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Corporate Officer/Principal | 01.08.2003 |
Ausbildung von Christopher Loose
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
94
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Semprus BioSciences Corp.
Semprus BioSciences Corp. Pharmaceuticals: GenericHealth Technology Develops medical devices for anti-microbial coating to reduce bloodstream infections | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products | Health Technology |
Center For Integration of Medicine & Innovative Technology | |
Yale School of Medicine
Yale School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage biotechnology company which develops small molecule drugs to repair damage caused by degenerative diseases | Health Technology |
